All Stories

  1. Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment

    Article • Cancers, January 2023, MDPI AG

    Dr Hiroyoshi Y. Tanaka

  2. Modeling and Analysis of Disease Microenvironments with 3D Cell Culture Technology

    Article • YAKUGAKU ZASSHI, May 2021, Pharmaceutical Society of Japan

    Dr Hiroyoshi Y. Tanaka

  3. 3D in vitro Model of Vascular Medial Thickening in Pulmonary Arterial Hypertension

    Article • Frontiers in Bioengineering and Biotechnology, May 2020, Frontiers

    Dr Hiroyoshi Y. Tanaka

  4. Heterotypic 3D pancreatic cancer model with tunable proportion of fibrotic elements

    Article • Biomaterials, April 2020, Elsevier

    Dr Hiroyoshi Y. Tanaka

  5. Antibiotic prescriptions for Japanese outpatients with acute respiratory tract infections (2013–2015): A retrospective Observational Study

    Article • Journal of Infection and Chemotherapy, March 2020, Elsevier

    Dr Hiroyoshi Y. Tanaka

  6. In vivo rendezvous of small nucleic acid drugs with charge-matched block catiomers to target cancers

    Article • Nature Communications, April 2019, Springer Science + Business Media

    Dr Hiroyoshi Y. Tanaka

  7. Oral anticoagulants usage in Japanese patients aged 18–74 years with non-valvular atrial fibrillation: a retrospective analysis based on insurance claims data

    Article • Family Practice, April 2019, Oxford University Press (OUP)

    Dr Hiroyoshi Y. Tanaka

  8. Stromal Barriers Within the Tumor Microenvironment and Obstacles to Nanomedicine

    Article • January 2019, Springer Science + Business Media

    Dr Hiroyoshi Y. Tanaka

  9. 3D Model of Pancreatic Cancer Fibrosis for the Study of Alterations in the Extracellular Matrix

    Article • Biomaterials, November 2018, Elsevier

    Dr Hiroyoshi Y. Tanaka

  10. Pattern of antibiotic prescriptions for outpatients with acute respiratory tract infections in Japan, 2013–15: a retrospective observational study

    Article • Family Practice, September 2018, Oxford University Press (OUP)

    Dr Hiroyoshi Y. Tanaka

  11. Factors which limit nanomedicine efficacy in pancreatic cancer

    Article • Cancer Science, May 2018, Wiley

    Dr Hiroyoshi Y. Tanaka

  12. Mural cells contribute to stabilize blood vessels by regulating endothelial cell apoptosis

    Article • Cancer Science, May 2017, Wiley

    Dr Hiroyoshi Y. Tanaka

  13. 3D in vitro model of fibrosis in pancreatic cancer to study drug delivery

    Article • Advanced Healthcare Materials, April 2017, Wiley

    Dr Hiroyoshi Y. Tanaka

  14. Fibrosis within pancreatic cancer impairs therapeutic efficacy of nanomedicine

    Article • Journal of Controlled Release, May 2016, Elsevier

    Dr Hiroyoshi Y. Tanaka

  15. The placenta after hypoxia/reoxygenation secretes factors damaging to the developing fetal brain

    Article • Experimental Neurology, November 2014, Elsevier

    Dr Hiroyoshi Y. Tanaka